These benefits, along with a previous report demonstrating that a small-molecule ACKR3 agonist CCX771 exhibits anxiolytic-like actions in mice,2 aid the idea of targeting ACKR3 as a novel technique to modulate the opioid system, which could open up new therapeutic avenues for opioid-relevant disorders. In combination with the described https://rogerg147nhe6.wikiannouncement.com/user